INTS vs JD
Intensity Therapeutics, Inc. Common stock (INTS) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
INTS currently screens at market cap $7.7M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the INTS and JD stock pages for the full models.
Not investment advice.